Patient-reported outcomes as end points in clinical trials in rheumatoid arthritis

There is a growing interest in patient-reported outcomes (PROs) in rheumatology, which goes with a global trend for more ‘patient-centred care’. This review considers the use of PROs in trials, including their strengths and limitations. In rheumatoid arthritis (RA) trials, the most frequently used P...

Descripción completa

Detalles Bibliográficos
Autores principales: Gossec, Laure, Dougados, Maxime, Dixon, William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613162/
https://www.ncbi.nlm.nih.gov/pubmed/26509052
http://dx.doi.org/10.1136/rmdopen-2014-000019

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613162/
https://www.ncbi.nlm.nih.gov/pubmed/26509052
http://dx.doi.org/10.1136/rmdopen-2014-000019

Ejemplares similares